[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335585-105":59,"doc-detail-335585-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gremlin-2-is-a-novel-tumor-suppressor-that-negatively-regulates-id1-in-breast-cancer","Gremlin-2 is a novel tumor suppressor that negatively regulates ID1 in breast cancer","","Breast cancer is a prevalent malignancy in women and is linked to obesity. Gremlin-2 (GREM2), a bone morphogenetic protein antagonist, has been studied mainly in adipogenic differentiation, but its actions in breast cancer cells remain unclear. Public-database bioinformatics combined with in vitro and in vivo overexpression and RNA-seq approaches evaluated GREM2 effects on viability, migration, and target-gene regulation. Results identify GREM2 as a suppressor of proliferation via ID1 regulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gremlin-2-is-a-novel-tumor-suppressor-that-negatively-regulates-id1-in-breast-cancer/335585/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gremlin-2-is-a-novel-tumor-suppressor-that-negatively-regulates-id1-in-breast-cancer/335585.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is Gremlin-2 (GREM2) and why study it in breast cancer?","Question",{"text":112,"@type":113},"GREM2 is an antagonist of bone morphogenetic proteins (BMPs). Its direct role in breast cancer cells has not been clearly defined despite evidence from other biological contexts.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do the experiments assess the function of GREM2 in breast cancer cells?",{"text":117,"@type":113},"The study uses bioinformatics plus in vitro and in vivo analyses with cells overexpressing mock or GREM2. It measures cell viability, colony formation, migration, and performs RNA-seq to identify GREM2-affected genes.",{"name":119,"@type":110,"acceptedAnswer":120},"What key pathway connects GREM2 to breast cancer cell behavior?",{"text":121,"@type":113},"GREM2 represses ID1 expression. BMP2 increases ID1, and restoring BMP2 or ID1 counteracts the suppressed migration phenotype associated with GREM2.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335585,1790218077,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":14,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Jung etal. Breast Cancer Research (2024) 26:174 Breast Cancer Research  \n[https://doi.org/10.1186/s13058-024-01935-1](https://doi.org/10.1186/s13058-024-01935-1)  \nRESEARCH Open Access  \nGremlin-2 is a novel tumor suppressor that negatively regulates ID1 in breast cancer  \nJiwoo Jung 1†, Na Hui Kim2†, Jayeon Park 1, Dayeon Lim 1, Minji Kwon 1, World Gil3, Suyeon Jung3, Minjeong Go3, Chaeeon Kim3, Ye Hwang Cheong4, Mee-Hyun Lee5, Hee Sun Park6, Yong-Bin Eom 1,3 and Sin-Aye Park 1,3*  \nAbstract  \nBackground Breast cancer is one of the most common cancers in women and is closely associated with obesity. Gremlin-2 (GREM2), an antagonist for bone morphogenetic proteins (BMPs), has been considered an inhibitor of adipogenic differentiation in adipose-derived stromal/stem cells. However, the role of GREM2 in breast cancer cells remains largely unknown, and its signaling mechanism has yet to be clarified.  \nMethods Bioinformatics analysis was conducted using public databases. Breast cancer cells overexpressing mock or GREM2 were used for in vitro and in vivo studies. Cell viability, colony formation, migration, and animal studies were performed to investigate the role of GREM2 in breast cancer cells. Screening of target genes affected by GREM2 overexpression in breast cancer cells was performed through RNA sequencing (RNA-seq) analysis.  \nResults The expression level of GREM2 mRNA was significantly reduced in both breast cancer tissues and cell lines. Kaplan-Meier analysis showed that low expression of GREM2 and high methylation of the GREM2 promoter were each associated with poor patient survival. The low mRNA expression of GREM2 in breast cancer cells was increased by the demethylating agent decitabine. Breast cancer cells overexpressing GREM2 decreased cell proliferation when compared to control cells, both in vitro and in vivo. Through comparison of RNA-seq analysis between cell lines and tissue samples, gene ontologies that were consistently upregulated or downregulated by GREM2 in breast cancer were identified. In particular, the expression of inhibitor of DNA-binding-1 (ID1) was repressed by GREM2 . BMP2 is oneof the upstream regulators that increases the expression of ID1, and the expression of ID1 reduced by GREM2 was restored by overexpression of BMP2 . Also, the migration ability of breast cancer cells, which had been suppressed by GREM2, was restored by BMP2 or ID1 .  \nConclusions Low expression of GREM2 in breast cancer cells is associated with hypermethylation of the GREM2 promoter, which may ultimately contribute to poor patient survival. GREM2 participates in regulating the expression of various genes, including ID1, and is involved in suppressing the proliferation of breast cancer cells. This suggests that GREM2 has the potential to act as a novel tumor suppressor in breast cancer.  \nKeywords Gremlin-2, Breast cancer, Hypermethylation, RNA sequencing, Inhibitor of DNA-binding-1, Tumor suppressor  \n†Jiwoo Jung and Na Hui Kim contributed equally to this work.  \n*Correspondence: Sin-Aye Park [sappark@sch.ac.kr](sappark@sch.ac.kr)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by","cbCaiojpKwvTBwnr","https://ap.wps.com/l/cbCaiojpKwvTBwnr","pdf",3265773,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Background\n## Breast cancer context\n## Gremlin-2 role in biology","[{\"question\":\"What is Gremlin-2 (GREM2) and why study it in breast cancer?\",\"answer\":\"GREM2 is an antagonist of bone morphogenetic proteins (BMPs). Its direct role in breast cancer cells has not been clearly defined despite evidence from other biological contexts.\"},{\"question\":\"How do the experiments assess the function of GREM2 in breast cancer cells?\",\"answer\":\"The study uses bioinformatics plus in vitro and in vivo analyses with cells overexpressing mock or GREM2. It measures cell viability, colony formation, migration, and performs RNA-seq to identify GREM2-affected genes.\"},{\"question\":\"What key pathway connects GREM2 to breast cancer cell behavior?\",\"answer\":\"GREM2 represses ID1 expression. BMP2 increases ID1, and restoring BMP2 or ID1 counteracts the suppressed migration phenotype associated with GREM2.\"}]","Gremlin-2 is a novel tumor suppressor that negatively regulates ID1 in breast cancer | PDF",1790011527,38,[147,151],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/4171088355d6f1cd8825af46a0dc68ba.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/f7b845597253fe0bb1dc1e5115899afc.webp",982,1309]